Medigus Ltd. (MDGS)

$5.0324

-0.19 (-3.59%)
Rating:
Recommendation:
Buy
Symbol MDGS
Price $5.0324
Beta 1.420
Volume Avg. 0.04M
Market Cap 8.250M
Shares () -
52 Week Range 4.445-19.5
1y Target Est -
DCF Unlevered MDGS DCF ->
DCF Levered MDGS LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E 23.96 Strong Buy
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest MDGS news


Christopher Rowland
Healthcare
Medical Devices
NASDAQ Capital Market

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.